Bristol-Myers Squibb Company (BMY)
Drug Manufacturers - General · Healthcare · $116.7B
Intrinsic Value (Consensus)
$48.07
Current Price
$57.13
Margin of Safety
-15.9%
15.9% Above Intrinsic Value
Value: $48
Price: $57
Valuation Model Estimates
Current Price: $57.13
DCF (Discounted Cash Flow)
$99.12
Graham Number
$26.56
Earnings Power Value
$33.59
Relative Value (P/E)
$69.20
Dividend Discount Model
$11.89
Consensus Value
$48.07
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Key Financials
- EPS (TTM)
- $3.46
- EPS (Forward)
- $3.63
- Book Value
- $9.06
- P/E Ratio
- 16.5
- Forward P/E
- 15.7
- PEG Ratio
- —
- ROE
- 38.2%
- Debt/Equity
- 243%
- Revenue Growth
- -0.2%
- Earnings Growth
- 5.0%
- Dividend Yield
- 1.1%
- Beta
- 0.24
Data last updated: 2026-06-12
Source: Yahoo Finance